Delivery Order SPE2DB22D2211-SPE2DB25FRTGN

Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,216.35 firm fixed price delivery order is for the supply of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ISENTRESS 400 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,239.02 and an ultimate completion date of April 26, 2024. The contract was awarded on April 25, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $125,872.27 firm fixed-price delivery order is for the supply of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.52 firm fixed-price delivery order is for the supply of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 24, 2023 and was awarded on November 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ISENTRESS 400 MG TABLET 60S. The contract has a ceiling value of $1,460.93 and a period of performance through March 11, 2025. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, under a Firm Fixed Price delivery order contract type. The contract is not designated as a set-aside....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,003.44 and a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. The specific award is for $4,741.00 to supply ISENTRESS 400 MG TABLET 60S, a prescription medication. This contract does not have a set-aside designation and will be performed in Conshohocken, PA. AmerisourceBergen,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,010.92 and is a Delivery Order with a Firm Fixed Price pricing type. The contract covers the procurement of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product, with a performance period through March 11, 2025. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,394.44 and is for the delivery of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a final completion date of January 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,296.18 Firm Fixed Price delivery order is for ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRTGN
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) for the delivery of ISENTRESS 400 MG TABLET 60S. The firm-fixed-price delivery order has a ceiling value of $3,849.72 and an ultimate completion date of March 17, 2025. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/13/25, 9:42 AM